Astellas Pharma Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALPMY Over the counter 2830 www.astellas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Astellas Pharma Inc.

New Strong Sell Stocks for August 6th - Aug 6th, 2026 2:30 am
Is Astellas Pharma (ALPMY) Stock Undervalued Right Now? - Jun 22nd, 2026 7:40 am
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? - Jun 22nd, 2026 7:40 am
Is Astellas Pharma (ALPMY) a Great Value Stock Right Now? - Jun 5th, 2026 7:40 am
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - Jun 5th, 2026 7:40 am
Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data? - Jun 3rd, 2026 9:39 am
MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer - May 25th, 2026 10:25 am
Are Medical Stocks Lagging Arcellx (ACLX) This Year? - Apr 27th, 2026 7:40 am
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight - Feb 10th, 2026 3:31 pm
Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption? - Feb 5th, 2026 6:48 am
Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment - Jan 8th, 2026 7:13 am